Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study
Autor: | Ehab R. Bendas, Mohamed A. El-Nabarawi, Yasmina Ahmed El-Attar, Hoda A Salem, Shaimaa El-Housiny, Dalia A. Attia, Maii Atef Shams Eldeen |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
Male
Antifungal Agents Sonication Chemistry Pharmaceutical Skin Absorption Pharmaceutical Science pityriasis versicolor 02 engineering and technology Topical Gel Administration Cutaneous 030226 pharmacology & pharmacy 03 medical and health sciences Colloid Surface-Active Agents 0302 clinical medicine Drug Delivery Systems topical delivery Pulmonary surfactant Solid lipid nanoparticle Tinea Versicolor fluconazole medicine entrapment efficiency Humans Prospective Studies Particle Size Drug Carriers Chromatography Chemistry lcsh:RM1-950 General Medicine Pityriasis clinical study 021001 nanoscience & nanotechnology medicine.disease Lipids carpabol 934 body regions solid lipid nanoparticles lcsh:Therapeutics. Pharmacology Poloxamer 407 Nanoparticles 0210 nano-technology Corrigendum Gels Fluconazole medicine.drug |
Zdroj: | Drug Delivery, Vol 25, Iss 1, Pp 78-90 (2018) Drug Delivery |
ISSN: | 1521-0464 1071-7544 |
Popis: | Solid lipid nanoparticles (SLNs) are very potential formulations for topical delivery of antifungal drugs. Hence, the purpose of this research was to formulate the well-known antifungal agent Fluconazole (FLZ)-loaded SLNs topical gel to improve its efficiency for treatment of Pityriasis Versicolor (PV). FLZ-SLNs were prepared by modified high shear homogenization and ultrasonication method using different concentration of solid lipid (Compritol 888 ATO, Precirol ATO5) and surfactant (Cremophor RH40, Poloxamer 407). The physicochemical properties and the in vitro release study for all FLZ-SLNs were investigated. Furthermore, the optimized FLZ-SLN formula was incorporated into gel using Carpobol 934. A randomized controlled clinical trial (RCT) of potential batches was carried out on 30 well diagnosed PV patients comparing to market product Candistan® 1% cream. Follow up was done for 4 weeks by clinical and KOH examinations. The results showed that FlZ-SLNs were almost spherical shape having colloidal sizes with no aggregation. The drug entrapment efficiency ranged from 55.49% to 83.04%. The zeta potential values lie between −21 and −33 mV presenting good stability. FLZ showed prolonged in vitro release from SLNs dispersion and its Carbapol gel following Higuchi order equation. Clinical studies registered significant improvement (p |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |